Abdulaziz Elgammal
- Role
- Co-founder & CPO of Proteinea
- Organisation
- Proteinea

About
Abdulaziz Elgammal is the Co-Founder and Chief Product Officer at Proteinea, an AI-native drug development company building an “evergreen” engine for therapeutic asset creation, with a core focus on engineering next generation antibody therapeutics. He works at the intersection of deep tech and biotech, translating frontier AI capabilities into real-world R&D products, partnerships, and investable pipelines. At Proteinea, Abdulaziz leads product strategy and execution across platform development and partner-facing programs. His work focuses on building repeatable, de-risked systems that can continuously generate high-value therapeutic candidates, helping position the company as a long-term biotech powerhouse in the MEA region. He is passionate about how capital, incentives, and product thinking shape the trajectory of deep tech startups, especially in domains where timelines are long, technical risk is real, and the reward is outsized impact. When he’s not thinking about molecules and models, you’ll likely find him in Cairo hunting for a great coffee, taking long city walks, and collecting stories from founders who are brave enough to build the future early.
Where to catch Abdulaziz
1 appearance over 1 day, in running order. Headline-stage sessions are marked in navy.
Day 1
Thursday
5 February1 slot
18:15to 18:45
Debate
The Funding Blind Spot: Are Deeptech Startups Overlooked?
Capital Stage
+15 Speakers
Also on the bill
All speakers26–28 December 2026 · Cairo
The Turning Point
Three days with thousands of people who are building the future of business, technology and culture.









